Slovin Shares Current State of Immunotherapy in Prostate Cancer – Targeted Oncology
Targeted Oncology |
Slovin Shares Current State of Immunotherapy in Prostate Cancer
Targeted Oncology In an interview with Targeted Oncology at the 2017 Interdisciplinary Prostate Cancer Congress, Slovin, a medical oncologist at Memorial Sloan Kettering Cancer Center, offered her expert insight on the current state of immunotherapy in prostate cancer. |
